ProShare Advisors
NDRM

ProShare Advisors’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

ProShare Advisors’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,655
Closed -$252K – 1784
2016
Q3 		$252K Sell
13,655
-2,464
-15% -$42.7K ﹤0.01% 1224
2016
Q2 		$262K Buy
16,119
+173
+1% +$2.91K ﹤0.01% 1270
2016
Q1 		$225K Sell
15,946
-1,374
-8% -$18.6K ﹤0.01% 1358
2015
Q4 		$295K Buy
+17,320
New +$337K ﹤0.01% 1299

Other funds holding NDRM

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ProShare Advisors's NDRM Position: Q4 2016 in Review

ProShare Advisors sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2016, closing a stake of 13,655 shares — an estimated $252K sold.

ProShare Advisors first reported a position in NDRM in Q4 2015 and held it in 4 quarters. The position peaked at $295K in Q4 2015. 56 funds tracked by Wall St. Rank hold NDRM as of Q4 2016.

  • ProShare Advisors reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2016 after selling out during the quarter.
  • ProShare Advisors sold 13,655 NeuroDerm Ltd. Ordinary Shares shares in Q4 2016, an estimated $252K.
  • ProShare Advisors first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2015 and held it in 4 quarters.
  • ProShare Advisors's NeuroDerm Ltd. Ordinary Shares position peaked at $295K in Q4 2015.
  • 56 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2016.

Based on ProShare Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.